Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATGross ProfitLong-Term Debt IssuancesReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Skinvisible (SKVI) Receivables - Other (2016 - 2023)

Skinvisible's Receivables - Other history spans 13 years, with the latest figure at $21592.0 for Q4 2023.

  • On a quarterly basis, Receivables - Other rose 53.43% to $21592.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $21592.0, a 53.43% increase, with the full-year FY2023 number at $21592.0, up 53.43% from a year prior.
  • Receivables - Other hit $21592.0 in Q4 2023 for Skinvisible, up from $14073.0 in the prior quarter.
  • Over the last five years, Receivables - Other for SKVI hit a ceiling of $68899.0 in Q4 2019 and a floor of $399.0 in Q2 2019.
  • Historically, Receivables - Other has averaged $16136.4 across 4 years, with a median of $9306.5 in 2019.
  • Biggest five-year swings in Receivables - Other: plummeted 96.01% in 2019 and later skyrocketed 995.24% in 2020.
  • Tracing SKVI's Receivables - Other over 4 years: stood at $68899.0 in 2019, then crashed by 93.66% to $4370.0 in 2020, then skyrocketed by 222.04% to $14073.0 in 2022, then soared by 53.43% to $21592.0 in 2023.
  • Business Quant data shows Receivables - Other for SKVI at $21592.0 in Q4 2023, $14073.0 in Q4 2022, and $4370.0 in Q2 2020.